Report Detail
Global Anti-Infective Vaccines Market Insights and Forecast to 2026
- RnM4122830 |
- 10 August, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Infective Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Infective Vaccines market is segmented into
Inactivated vaccines
Conjugate vaccines
Live/attenuated vaccines
Segment by Application, the Anti-Infective Vaccines market is segmented into
Bacterial diseases
Viral diseases
Regional and Country-level Analysis
The Anti-Infective Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Infective Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Infective Vaccines Market Share Analysis
Anti-Infective Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Infective Vaccines business, the date to enter into the Anti-Infective Vaccines market, Anti-Infective Vaccines product introduction, recent developments, etc.
The major vendors covered:
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
1 Study Coverage
- 1.1 Anti-Infective Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Infective Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type
- 1.4.2 Inactivated vaccines
- 1.4.3 Conjugate vaccines
- 1.4.4 Live/attenuated vaccines
- 1.5 Market by Application
- 1.5.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application
- 1.5.2 Bacterial diseases
- 1.5.3 Viral diseases
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Infective Vaccines Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Infective Vaccines Revenue 2015-2026
- 2.1.2 Global Anti-Infective Vaccines Sales 2015-2026
- 2.2 Global Anti-Infective Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Infective Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Infective Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Infective Vaccines Competitor Landscape by Players
- 3.1 Anti-Infective Vaccines Sales by Manufacturers
- 3.1.1 Anti-Infective Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Infective Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Infective Vaccines Revenue by Manufacturers
- 3.2.1 Anti-Infective Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Revenue in 2019
- 3.2.5 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Infective Vaccines Price by Manufacturers
- 3.4 Anti-Infective Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Infective Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Infective Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Infective Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Anti-Infective Vaccines Revenue by Type (2015-2020)
- 4.1.3 Anti-Infective Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Infective Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Infective Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Infective Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Infective Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Infective Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Infective Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Infective Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Anti-Infective Vaccines Revenue by Application (2015-2020)
- 5.1.3 Anti-Infective Vaccines Price by Application (2015-2020)
- 5.2 Anti-Infective Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Infective Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Infective Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Infective Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Infective Vaccines by Country
- 6.1.1 North America Anti-Infective Vaccines Sales by Country
- 6.1.2 North America Anti-Infective Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Infective Vaccines Market Facts & Figures by Type
- 6.3 North America Anti-Infective Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Infective Vaccines by Country
- 7.1.1 Europe Anti-Infective Vaccines Sales by Country
- 7.1.2 Europe Anti-Infective Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Infective Vaccines Market Facts & Figures by Type
- 7.3 Europe Anti-Infective Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Infective Vaccines by Region
- 8.1.1 Asia Pacific Anti-Infective Vaccines Sales by Region
- 8.1.2 Asia Pacific Anti-Infective Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Infective Vaccines by Country
- 9.1.1 Latin America Anti-Infective Vaccines Sales by Country
- 9.1.2 Latin America Anti-Infective Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Infective Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Anti-Infective Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Infective Vaccines by Country
- 10.1.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
- 10.1.2 Middle East and Africa Anti-Infective Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 Emergent BioDefense Operations Lansing Inc.
- 11.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
- 11.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
- 11.1.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
- 11.1.5 Emergent BioDefense Operations Lansing Inc. Related Developments
- 11.2 Sanofi Pasteur
- 11.2.1 Sanofi Pasteur Corporation Information
- 11.2.2 Sanofi Pasteur Description and Business Overview
- 11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
- 11.2.5 Sanofi Pasteur Related Developments
- 11.3 Merck & Co.
- 11.3.1 Merck & Co. Corporation Information
- 11.3.2 Merck & Co. Description and Business Overview
- 11.3.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
- 11.3.5 Merck & Co. Related Developments
- 11.4 MedImmune LLC
- 11.4.1 MedImmune LLC Corporation Information
- 11.4.2 MedImmune LLC Description and Business Overview
- 11.4.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
- 11.4.5 MedImmune LLC Related Developments
- 11.5 Novartis Vaccines
- 11.5.1 Novartis Vaccines Corporation Information
- 11.5.2 Novartis Vaccines Description and Business Overview
- 11.5.3 Novartis Vaccines Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
- 11.5.5 Novartis Vaccines Related Developments
- 11.6 Diagnostics Ltd.
- 11.6.1 Diagnostics Ltd. Corporation Information
- 11.6.2 Diagnostics Ltd. Description and Business Overview
- 11.6.3 Diagnostics Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
- 11.6.5 Diagnostics Ltd. Related Developments
- 11.7 Intercell Biomedical
- 11.7.1 Intercell Biomedical Corporation Information
- 11.7.2 Intercell Biomedical Description and Business Overview
- 11.7.3 Intercell Biomedical Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
- 11.7.5 Intercell Biomedical Related Developments
- 11.8 MassBiologics
- 11.8.1 MassBiologics Corporation Information
- 11.8.2 MassBiologics Description and Business Overview
- 11.8.3 MassBiologics Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 MassBiologics Anti-Infective Vaccines Products Offered
- 11.8.5 MassBiologics Related Developments
- 11.9 Barr Labs, Inc.
- 11.9.1 Barr Labs, Inc. Corporation Information
- 11.9.2 Barr Labs, Inc. Description and Business Overview
- 11.9.3 Barr Labs, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
- 11.9.5 Barr Labs, Inc. Related Developments
- 11.10 Organon Teknika Co.
- 11.10.1 Organon Teknika Co. Corporation Information
- 11.10.2 Organon Teknika Co. Description and Business Overview
- 11.10.3 Organon Teknika Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
- 11.10.5 Organon Teknika Co. Related Developments
- 11.1 Emergent BioDefense Operations Lansing Inc.
- 11.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
- 11.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
- 11.1.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
- 11.1.5 Emergent BioDefense Operations Lansing Inc. Related Developments
- 11.12 CSL Ltd.
- 11.12.1 CSL Ltd. Corporation Information
- 11.12.2 CSL Ltd. Description and Business Overview
- 11.12.3 CSL Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 CSL Ltd. Products Offered
- 11.12.5 CSL Ltd. Related Developments
- 11.13 ID Biomedical Co.
- 11.13.1 ID Biomedical Co. Corporation Information
- 11.13.2 ID Biomedical Co. Description and Business Overview
- 11.13.3 ID Biomedical Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 ID Biomedical Co. Products Offered
- 11.13.5 ID Biomedical Co. Related Developments
- 11.14 Protein Sciences Co.
- 11.14.1 Protein Sciences Co. Corporation Information
- 11.14.2 Protein Sciences Co. Description and Business Overview
- 11.14.3 Protein Sciences Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Protein Sciences Co. Products Offered
- 11.14.5 Protein Sciences Co. Related Developments
- 11.15 Wyeth Pharmaceuticals, Inc.
- 11.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
- 11.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
- 11.15.3 Wyeth Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
- 11.15.5 Wyeth Pharmaceuticals, Inc. Related Developments
- 11.16 Berna Biotech
- 11.16.1 Berna Biotech Corporation Information
- 11.16.2 Berna Biotech Description and Business Overview
- 11.16.3 Berna Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Berna Biotech Products Offered
- 11.16.5 Berna Biotech Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Infective Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Anti-Infective Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Infective Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Infective Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Infective Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Infective Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Infective Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Infective Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Infective Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Infective Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Infective Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Infective Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Infective Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Infective Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Infective Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Infective Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Infective Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Infective Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Infective Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Infective Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Infective Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Infective Vaccines. Industry analysis & Market Report on Anti-Infective Vaccines is a syndicated market report, published as Global Anti-Infective Vaccines Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-Infective Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
